Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 12251-12300 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06296836
Effect of Continuing Versus Holding Metformin During Hospitalizations.
PHASE4Recruiting
300 participants
Started: Jan 21, 2025 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT06780709
Impact of a Structured Wellness Behavioral Intervention on Quality of Life in NMOSD
NARecruiting
20 participants
Started: Jan 21, 2025 · Completed: Jan 31, 2028
1 condition1 sponsor1 location
NCT06824350
Clean Trial - Chlorination to Reduce Enteric and Antibiotic Resistant Infections in Neonates
NARecruiting
45,450 participants
Started: Jan 21, 2025 · Completed: Jul 31, 2027
5 conditions4 sponsors2 locations
NCT06679036
A Trial of HRS-2189 in Combination With Fluvastatin±HRS-6209, or HRS-8080±HRS-6209, or HRS-6209+HRS-1358 in Breast Cancer Patients
PHASE1/PHASE2Recruiting
300 participants
Started: Jan 21, 2025 · Completed: Dec 31, 2026
1 condition1 sponsor2 locations
NCT06701851
Neural Correlates of Movement Disorders Associated With PRRT2 Related Paroxysmal Kinesigenic Dyskinesia - an Ancillary Study of AMEDYST Research
NARecruiting
1 participants
Started: Jan 21, 2025 · Completed: Nov 30, 2028
1 condition1 sponsor1 location
NCT06940011
Endocalyx in Treatment Resistent Hypertension
PHASE2Recruiting
64 participants
Started: Jan 21, 2025 · Completed: Jan 1, 2028
1 condition4 sponsors1 location
NCT06580067
The Feasibility of the Pray Until Something Happens (PUSH) Intervention-OUTPATIENT
NARecruiting
40 participants
Started: Jan 21, 2025 · Completed: Nov 30, 2025
3 conditions1 sponsor1 location
NCT06532071
Advanced Imaging for Pulmonary Fibrosis
PHASE2Recruiting
60 participants
Started: Jan 21, 2025 · Completed: Dec 31, 2028
1 condition1 sponsor1 location
NCT06799624
Prognostic Role of molEcular classiFication in Fertility-sparing treAtment of Endometrial canCEr
N/ARecruiting
100 participants
Started: Jan 21, 2025 · Completed: Jan 31, 2028
1 condition1 sponsor1 location
NCT06781931
DG1 Spectacle Lens for Myopia Progression Control in Children
NARecruiting
240 participants
Started: Jan 21, 2025 · Completed: Jan 31, 2030
1 condition1 sponsor10 locations
NCT06851611
The Safety and Antibody Response of the Nasal COV2 Vaccine Against the SARS-CoV-2 Virus
PHASE1Recruiting
50 participants
Started: Jan 21, 2025 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT06821516
Comparison of Pain Relief Methods for Hip Surgery: A Study on Two Different Nerve Block Techniques
NARecruiting
52 participants
Started: Jan 21, 2025 · Completed: Jun 1, 2026
7 conditions1 sponsor1 location
NCT04084795
Augmentation of EMDR With tDCS in the Treatment of Fibromyalgia
NARecruiting
96 participants
Started: Jan 21, 2025 · Completed: Dec 31, 2026
4 conditions2 sponsors1 location
NCT06745882
Prospective Trial Assessing Real World Outcomes Response to Pembro in Black Patients w/ NSCLC
PHASE2Recruiting
318 participants
Started: Jan 21, 2025 · Completed: Jan 31, 2030
1 condition4 sponsors1 location
NCT06804967
Effects of Virtual Reality Relaxation on the Anxiety Levels
NARecruiting
62 participants
Started: Jan 21, 2025 · Completed: Jan 31, 2026
1 condition1 sponsor1 location
NCT06563596
Epco, Zanu, Ritux for R/R FL or MZL
PHASE2Recruiting
45 participants
Started: Jan 21, 2025 · Completed: Mar 1, 2030
6 conditions3 sponsors2 locations
NCT05959616
Shigella Sonnei 53G Human Infection Study in Kenyan Adults
PHASE1Recruiting
70 participants
Started: Jan 21, 2025 · Completed: Aug 30, 2027
1 condition7 sponsors1 location
NCT06799832
Urethral PeRfusion Index-Guided Hemodynamic ManagemenT in Patients Having Major Abdominal Surgery: the UPRIGHT Randomized Feasibility Trial
NARecruiting
116 participants
Started: Jan 21, 2025 · Completed: Jul 31, 2025
3 conditions1 sponsor2 locations
NCT06646055
AK112 and Cadonilimab Combined With Chemotherapy for 1L Treatment of Metastatic Pancreatic Cancer
PHASE1/PHASE2Recruiting
110 participants
Started: Jan 21, 2025 · Completed: Dec 30, 2027
1 condition1 sponsor1 location
NCT05541276
MELAtonin for Prevention of Postoperative Agitation and Emergence Delirium in Children
PHASE3Recruiting
400 participants
Started: Jan 21, 2025 · Completed: Jan 1, 2027
1 condition4 sponsors1 location
NCT06809660
Effects of Endocrine Disruptors on the Gut Microbiota and Assessment of Their Impact on Colorectal Cancer Development (PERMICA)
NARecruiting
200 participants
Started: Jan 21, 2025 · Completed: Jan 21, 2034
4 conditions2 sponsors1 location
NCT06657989
Optimal Intensity of Reactive Balance Training for Healthy Older Adults
NARecruiting
96 participants
Started: Jan 21, 2025 · Completed: Dec 31, 2027
1 condition2 sponsors1 location
NCT06585774
A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
PHASE3Recruiting
240 participants
Started: Jan 21, 2025 · Completed: Mar 31, 2030
1 condition1 sponsor95 locations
NCT06805448
Intraglandular Treatment With Adipose-derived Mesenchymal Stem Cells in Patients With Xerostomia Due to Sjögren's Disease
PHASE1/PHASE2Recruiting
40 participants
Started: Jan 21, 2025 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06607406
Postoperative Radiotherapy for Intermediate- and High-risk Patients With HNSCC Greater Than 6 Weeks After Surgery
NARecruiting
75 participants
Started: Jan 21, 2025 · Completed: Jan 31, 2030
2 conditions1 sponsor3 locations
NCT06825819
Dysbiosis & Long COVID
N/ARecruiting
400 participants
Started: Jan 21, 2025 · Completed: Jan 31, 2029
1 condition1 sponsor1 location
NCT06690658
Self-Practicing Upper Body Exercises with a Robotic Trainer System
NARecruiting
30 participants
Started: Jan 21, 2025 · Completed: Jan 31, 2027
2 conditions1 sponsor1 location
NCT06366269
Acupuncture First for IC/BPS
NARecruiting
34 participants
Started: Jan 21, 2025 · Completed: Oct 31, 2026
2 conditions1 sponsor1 location
NCT06737731
A Phase I/II Clinical Study of SHR-1681 for Injection in Patients With Advanced Solid Tumors
PHASE1/PHASE2Recruiting
300 participants
Started: Jan 21, 2025 · Completed: Jul 31, 2027
1 condition1 sponsor1 location
NCT06694714
Split Face Study of the Duration of Local Anesthetics - Fourth Arm
PHASE4Recruiting
25 participants
Started: Jan 21, 2025 · Completed: Jun 1, 2025
1 condition1 sponsor1 location
NCT06733558
Long-term Potentiation Disruption Underlying Cognitive Impairment in ECT
EARLY_PHASE1Recruiting
10 participants
Started: Jan 21, 2025 · Completed: Jul 31, 2026
2 conditions2 sponsors1 location
NCT06739408
Protein Source and Resistance Training
NARecruiting
72 participants
Started: Jan 21, 2025 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT06744556
HAV Versus DAV/IAV Induction Regimen in Elderly Patients With AML
PHASE2Recruiting
60 participants
Started: Jan 21, 2025 · Completed: Jun 1, 2027
1 condition1 sponsor1 location
NCT06891716
[18F]ACI-19626 PET in TDP-43 Proteinopathies
EARLY_PHASE1Recruiting
45 participants
Started: Jan 21, 2025 · Completed: Nov 30, 2026
5 conditions2 sponsors1 location
NCT06745609
Prehabilitation Prior to Surgery for Kidney Tumors
NARecruiting
60 participants
Started: Jan 21, 2025 · Completed: Mar 31, 2032
6 conditions1 sponsor1 location
NCT06890975
"F!reF!ghterF!t: Lifestyle Coaching Interventions for Obese Firefighters (FireFit)"
NARecruiting
50 participants
Started: Jan 21, 2025 · Completed: Jan 31, 2026
1 condition2 sponsors1 location
NCT06768762
Optimizing a Remote-based Physical Activity Intervention for Adults with Total Knee Replacement
NARecruiting
336 participants
Started: Jan 21, 2025 · Completed: Jul 31, 2029
1 condition2 sponsors1 location
NCT06769269
Hypertension Registry: Study of Primary and Secondary Hypertension Phenotypes, Complications, and Treatment Personalization.
N/ARecruiting
10,000 participants
Started: Jan 21, 2025 · Completed: Jan 21, 2027
1 condition2 sponsors5 locations
NCT06774287
Evaluation of the Karman Line Memory Strategy Training
NARecruiting
6 participants
Started: Jan 21, 2025 · Completed: Dec 15, 2025
1 condition1 sponsor1 location
NCT06753838
Choice of Anticoagulant for Primary Hemostasis Studies With PFA200® (Platelet Function Analyser)
N/ARecruiting
100 participants
Started: Jan 21, 2025 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06341023
Functional Balance Intervention in Multiple Sclerosis
NARecruiting
120 participants
Started: Jan 21, 2025 · Completed: Jan 9, 2027
1 condition1 sponsor1 location
NCT05911269
Feasibility of Virtual, Tailored, Music-Based Relaxation for Anxiety in Adolescent and Young Adult Cancer Survivors
NARecruiting
50 participants
Started: Jan 21, 2025 · Completed: Jun 30, 2030
1 condition2 sponsors1 location
NCT06674889
Rehabilitation Outcomes Study
NARecruiting
40 participants
Started: Jan 21, 2025 · Completed: Feb 28, 2026
2 conditions1 sponsor1 location
NCT06797466
Three Dimensional Virtual Reconstruction (3D) in Percutaneous Nephrolithotomy
NARecruiting
100 participants
Started: Jan 21, 2025 · Completed: Oct 31, 2025
2 conditions1 sponsor1 location
NCT06835647
Maternal Fetal Device Performance Twins
NARecruiting
15 participants
Started: Jan 21, 2025 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05706311
Community Pharmacy-Based Prescription Drug Monitoring Program Opioid Risk Assessment Tool
NARecruiting
80 participants
Started: Jan 21, 2025 · Completed: Jul 30, 2026
2 conditions3 sponsors2 locations
NCT06480591
Evaluation of the Pathobiology of CALR-mutated MPN Cells
N/ARecruiting
35 participants
Started: Jan 21, 2025 · Completed: Feb 28, 2026
1 condition3 sponsors2 locations
NCT06945978
Validation of a miRNA Panel to Optimize Treatment Response in Patients With Metastatic Pancreatic Cancer (mirPANC 2)
N/ARecruiting
60 participants
Started: Jan 21, 2025 · Completed: Dec 31, 2027
3 conditions1 sponsor1 location
NCT06664333
Experiences Reported by Siblings of Children Hospitalized in the PICU
N/ARecruiting
15 participants
Started: Jan 21, 2025 · Completed: Nov 21, 2025
1 condition2 sponsors2 locations
NCT06613360
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
PHASE1Recruiting
24 participants
Started: Jan 21, 2025 · Completed: Dec 31, 2027
2 conditions1 sponsor12 locations